01.01.06
Novartis Sells Nutrition & Health Unit to Private Equity Firm
Novartis, Basel, Switzerland, recently sold its nutrition and health food unit to ABN AMRO Capital France, the global private equity business of Dutch banking group ABN AMRO, for €220 million. The unit markets products under the names of Gerble, Isostar, Cereal and Gerlinea. Novartis sold the unit so it could concentrate on pharmaceutical and health activities.
Novartis, Basel, Switzerland, recently sold its nutrition and health food unit to ABN AMRO Capital France, the global private equity business of Dutch banking group ABN AMRO, for €220 million. The unit markets products under the names of Gerble, Isostar, Cereal and Gerlinea. Novartis sold the unit so it could concentrate on pharmaceutical and health activities.